Expand Document  |  Expand Chapter  |  Full TOC  |  Printable HTML version
Containing Antimicrobial Resistance - WHO Policy Perspectives on Medicines, No. 010, April 2005
(2005; 6 pages) [French] [Spanish] View the PDF document
Table of Contents
View the documentThe problem of antimicrobial resistance
View the documentMeasuring the problem through surveillance
View the documentEpidemiological surveillance of antimicrobial resistance
View the documentSurveillance of antimicrobial use
View the documentCore national strategies to contain AMR
View the documentConclusion
View the documentKey Documents

Epidemiological surveillance of antimicrobial resistance

Resistance varies widely with geographical location, type of community and level of health facility. There-fore local surveillance data should be used to guide clinical management and update clinical guidelines, educate prescribers and guide infection control policies. Data should distinguish between hospital nosocomial and community-acquired infections and should exclude duplicate isolates from the same patient.

A national antimicrobial surveillance system should consist of:

• national reference microbiology laboratory facilities to coordinate epidemiologically sound surveillance of AMR in common pathogens in the community, hospitals and other health care facilities;

•a network of laboratories, all with adequate internal and external quality assurance, that regularly collect and report relevant resistance data and provide quality microbiological diagnostic services.


to previous section
to next section
The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: December 6, 2017